Last updated: June 1, 2026
Suppliers for naloxone hydrochloride and pentazocine hydrochloride split into three practical procurement routes: (1) API manufacturers, (2) finished-dose drug manufacturers that sell directly to distributors, and (3) contract manufacturers and private-label program partners that source APIs and fill/pack finished forms for branded and generic channels.
No supplier list is possible from the information provided. The drug names alone do not uniquely determine (a) dosage form and strength (injection vs. tablets; concentration and pack size), (b) intended market (US, EU, UK, India, Canada), (c) regulatory status (FDA approved vs. not), (d) whether you mean API (active) suppliers or finished-dose suppliers, or (e) whether you want current approved partners only.
As a result, an accurate, business-ready supplier table cannot be produced without additional sourcing parameters.
What suppliers make naloxone hydrochloride APIs and finished-dose products?
Featured snippet answer: Naloxone supply commonly comes from API producers plus finished-dose sterile injection manufacturers. API and injectable contract manufacturing are the usual bottlenecks.
Which naloxone hydrochloride products drive supplier choice?
- Sterile injection (most procurement-relevant for naloxone): supplier eligibility depends on parenteral manufacturing capacity and sterility assurance.
- Dosage strength and container-closure: e.g., prefilled syringe vs. vial affects who can qualify.
US vs. EU vs. India: why “suppliers” differ
- US channel generally ties to FDA-registered facilities and (for generics) ANDA-listed manufacturing records.
- EU procurement typically tracks EMA-related manufacturing authorizations and QP release frameworks.
- India-based supply often competes on API capacity and scale, then feeds finished-dose OEMs.
What suppliers make pentazocine hydrochloride APIs and finished-dose products?
Featured snippet answer: Pentazocine is supplied through opioid CMO and API producers, then packaged into injectable or oral dosage forms depending on market demand.
Which pentazocine hydrochloride products drive supplier choice?
- Injection: requires opioid-safe controlled manufacturing and distribution controls.
- Oral dosage forms (where marketed): drives different formulation and packaging requirements than sterile supply.
Regulatory and distribution constraints that narrow the supplier pool
- Opioid manufacturing and distribution is subject to controlled-substance rules, which can limit both contract manufacturing and warehouse-distributor participation depending on geography.
Who are the API suppliers for naloxone hydrochloride by procurement route?
Featured snippet answer: API procurement is usually handled via direct API manufacturers or brokers that maintain compliance documentation and batch COA traceability.
Typical API procurement documentation buyers require
- GMP status and facility registration
- COA and impurity profiles
- Supply continuity and batch scheduling for sterile customers (if API is used in injectable plants)
Who are the API suppliers for pentazocine hydrochloride by procurement route?
Featured snippet answer: Pentazocine API supply is typically limited by controlled-manufacturing capacity and opioid supply chain compliance.
Typical buyer requirements
- Facility permissions for controlled substances (where applicable)
- Validation packages for impurity specs and particle size (for solid dosage form downstream)
Which companies supply naloxone hydrochloride finished injections in the US?
Featured snippet answer: Finished-dose suppliers are those with an FDA-approved labeling record (branded or generic) and sterile manufacturing capability. Distributor listings reflect that set.
What procurement plans need for sterile supply
- Lead times for vials vs. prefilled syringes
- Cold-chain requirements if any (varies by labeled product)
- Packaging (NDC configuration) matching distribution contracts
Which companies supply pentazocine hydrochloride finished injections in the US?
Featured snippet answer: Finished-dose suppliers are the FDA-approved manufacturers for the specific strength, dosage form, and package configuration. Opioid chain controls can affect availability.
What procurement plans need for controlled-opioid supply
- DEA and state-level distribution compliance readiness
- Contract clauses for lot-level traceability and recall support
How do you compare naloxone vs. pentazocine supplier networks?
Featured snippet answer: Naloxone tends to have a broader generic injection ecosystem, while pentazocine supplier availability can be more constrained by controlled-substance manufacturing and market-specific approvals.
Comparison dimensions buyers use
- API availability and pricing stability
- Sterile manufacturing readiness (for injection SKUs)
- Packaging and NDC alignment with contracts
- Quality system maturity and inspection history (where surfaced in public records)
What generic launch or ANDA timing affects supplier availability?
Featured snippet answer: Supplier availability and pricing are shaped by FDA ANDA/label expansions, facility changes, and patent-driven entry windows.
Where timing matters most
- When new generic strengths enter
- When contract manufacturing transfers occur
- When inspection or quality events constrain supply
Key Takeaways
- “Suppliers” for naloxone hydrochloride and pentazocine hydrochloride depends on whether you need API or finished-dose products, the dosage form, and the target market.
- Naloxone injection procurement typically emphasizes sterile parenteral manufacturing and dose container-closure fit.
- Pentazocine procurement typically emphasizes opioid-controlled manufacturing and distribution compliance plus injectable or oral dosage-form capability.
- A correct supplier roster requires at least dosage form/strength, API vs finished-dose definition, and geography.
FAQs
- Are naloxone hydrochloride API suppliers the same as finished-dose injection manufacturers?
- How do sterile manufacturing constraints affect naloxone injection supplier qualification?
- What compliance requirements most restrict pentazocine hydrochloride contract manufacturing?
- Does the supplier roster change by NDC package size and container type?
- How do ANDA approvals typically influence finished-dose supplier availability?
References
- FDA, Orange Book (Drug Products and Patents) database.
- FDA Drug Registration and Listing System (DRLS).
- FDA Current Good Manufacturing Practice (cGMP) guidance and enforcement resources.
